Immunovant, Inc.
Immunovant, Inc.（IMVT）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · IMVT · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
38
近12个月
买卖比
0.03
Buy/Sell (by trades)
整体情绪
Immunovant, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
IMVT 季度内部人买卖趋势
IMVT 内幕交易卖出 · IMVT 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · IMVT CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
IMVT 高管卖出股份 · IMVT 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| May 28, 2026 | Fromkin Andrew J. Director | Option | 16,260 | $239K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Sale | 11,483 | $375K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Option | 77,181 | $651K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Option | 71,492 | $568K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Option | 31,668 | $158K | Form 4 |
| May 28, 2026 | Fromkin Andrew J. Director | Sale | 210,468 | $7.06M⚡ | Form 4 |
| May 20, 2026 | Gloria Melanie COO | Sale | 249 | $8K | Form 4 |
| May 20, 2026 | Gloria Melanie COO | Sale | 1,168 | $38K | Form 4 |
| May 20, 2026 | Gloria Melanie COO | Sale | 1,698 | $56K | Form 4 |
| May 20, 2026 | Pande Atul Director | Option | 6,000 | $51K | Form 4 |
| May 20, 2026 | Pande Atul Director | Sale | 6,000 | $192K | Form 4 |
| May 1, 2026 | Susman Robert Graham Director | Sale | 2,502 | $68K | Form 4 |
| Apr 23, 2026 | Girao Tiago CFO | Sale | 25,760 | $763K | Form 4 |
| Apr 23, 2026 | Stout Jay S CTO | Sale | 2,754 | $82K | Form 4 |
| Apr 8, 2026 | Van Tuyl Christopher Chief Legal Officer | Sale | 5,165 | $128K | Form 4 |
| Apr 8, 2026 | Gloria Melanie COO | Sale | 8,722 | $217K | Form 4 |
| Apr 8, 2026 | Stout Jay S CTO | Sale | 8,614 | $214K | Form 4 |
| Apr 8, 2026 | Stout Jay S CTO | Sale | 1,518 | $38K | Form 4 |
| Apr 7, 2026 | Torti Frank Director | Award | 174,189 | — | Form 4 |
| Apr 7, 2026 | Fromkin Andrew J. Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Hughes Douglas J. Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Pande Atul Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Bauer Jake Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Susman Robert Graham Director | Award | 13,880 | — | Form 4 |
| Apr 7, 2026 | Gloria Melanie COO | Award | 83,671 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 IMVT 内幕交易
IMVT 内幕交易
Immunovant, Inc.（IMVT）内幕交易数据来源于公司内部人（包括Stout Jay S (CTO), Gloria Melanie (COO), Fromkin Andrew J. (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。IMVT内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Immunovant, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
IMVT 内幕交易 · 5个问题Immunovant, Inc.（IMVT）的内部人包括高管和董事，如Stout Jay S (CTO), Gloria Melanie (COO), Fromkin Andrew J. (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026